Medication info
Zitrams CR Sustained Release Tablet 75 mg (Tramadol Hydrochloride)

Zitrams CR Sustained Release Tablet 75 mg (Tramadol Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›75mg / 1 tablet
Manufacturer / importer
Mundipharma Korea Ltd
Appearance
Light gray, biconvex, round, film-coated sustained release tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201109819 · Approved 2011.11.09 · Insurance code 678000230

Summary

Main use
Relief of moderate to severe acute and chronic pain (e.g., cancer pain) and pain after diagnostic procedures or surgery
Who takes it
Adults
Adult dose
The dose of this medicine should be adjusted according to the patient's pain intensity and clinical response. In general, administer the lowest dose that relieves the pain. The appropriate dose for each patient is the dose that controls pain without adverse effects or with only mild, tolerable adverse effects. Unless there are special clinical circumstances, do not exceed 400mg/day of tramadol hydrochloride. Adults The initial dose of this medicine is 1 tablet (75 milligrams) per dose, twice daily at 12-hour intervals. Swallow this medicine whole without chewing. To minimize transient adverse effects, it is preferable to increase the dose gradually. Withdrawal symptoms and drug dependence have been reported; therefore, if continued administration is necessary, regularly evaluate the need for continued treatment. For patients who have been receiving immediate-release tramadol hydrochloride, calculate the total daily dose and initiate this medicine at the dose closest to the dosage range of this medicine. Elderly No dose adjustment is required in patients 75 years of age or younger without clinically confirmed hepatic or renal impairment. In patients over 75 years of age, elimination of this medicine may be delayed; adjust the dosing interval if necessary. Patients with renal impairment/on dialysis or hepatic impairment Elimination of this medicine may be delayed in patients with renal or hepatic impairment; consider extending the dosing interval in these patients.

Ingredients

Importer
Mundipharma Korea Ltd

Efficacy & effects

Relief of moderate to severe acute and chronic pain (e.g., cancer pain) and pain after diagnostic procedures or surgery

  • Severe pain
  • moderate acute chronic pain
  • acute chronic pain
  • various cancer pains
  • pain after diagnosis
  • pain after surgery
View approved original text

This medication is used to relieve severe and moderate acute and chronic pain, particularly pain caused by various cancers and pain that occurs after diagnosis and surgery.

How to take

Adult dose

The dose of this medicine should be adjusted according to the patient's pain intensity and clinical response. In general, administer the lowest dose that relieves the pain. The appropriate dose for each patient is the dose that controls pain without adverse effects or with only mild, tolerable adverse effects. Unless there are special clinical circumstances, do not exceed 400mg/day of tramadol hydrochloride. Adults The initial dose of this medicine is 1 tablet (75 milligrams) per dose, twice daily at 12-hour intervals. Swallow this medicine whole without chewing. To minimize transient adverse effects, it is preferable to increase the dose gradually. Withdrawal symptoms and drug dependence have been reported; therefore, if continued administration is necessary, regularly evaluate the need for continued treatment. For patients who have been receiving immediate-release tramadol hydrochloride, calculate the total daily dose and initiate this medicine at the dose closest to the dosage range of this medicine. Elderly No dose adjustment is required in patients 75 years of age or younger without clinically confirmed hepatic or renal impairment. In patients over 75 years of age, elimination of this medicine may be delayed; adjust the dosing interval if necessary. Patients with renal impairment/on dialysis or hepatic impairment Elimination of this medicine may be delayed in patients with renal or hepatic impairment; consider extending the dosing interval in these patients.

Precautions

Using this medication in excess of the recommended dose can cause seizures, so it is crucial to adhere to the prescribed dosages. Furthermore, patients with epilepsy or a risk of seizures should use this medication only when absolutely necessary, and caution is needed if they are taking other medications that increase the risk of seizures. Long-term use may result in psychological and physical dependence, so it should be used only for a short duration under strict supervision in patients with a history of drug abuse or dependence. Taking this medication with other central nervous system depressants or alcohol can lead to severe drowsiness, respiratory depression, hypotension, or coma, hence great caution is needed when combining with these substances. Additionally, some individuals may metabolize this medication very rapidly, leading to unexpectedly strong medication effects and increased risk of respiratory depression, so dosage adjustments and symptom monitoring are necessary in such cases. This medication should not be used in children under 12 years of age or adolescents under 18 years of age who have undergone tonsillectomy or adenoidectomy. For adolescents between 12 and 18 years of age, it is advisable to avoid administration if there are specific risk factors. This medication can cause sleep apnea or hypoxemia; therefore, continuous monitoring for the occurrence or worsening of these symptoms is necessary, and dosage may need to be gradually reduced or stopped if required. It should not be used in patients with acute alcohol intoxication, central nervous system drug poisoning, severe respiratory depression, head trauma, those who have taken MAO inhibitors recently, patients with severe renal or liver dysfunction, pregnant or breastfeeding women, children under 12 years, or patients with allergies to this medication or opioids. Additionally, patients who are using morphine concurrently or repetitively, those with biliary disease or liver dysfunction, drinkers, patients sensitive to opioids, those with renal impairment, patients with a history of seizures, and those with a history of psychological dependence or drug abuse should use this medication with caution. During the course of treatment, symptoms such as drowsiness, dizziness, and nausea may occur, so it is advisable to avoid driving or operating hazardous machinery. Long-term use can result in tolerance, necessitating higher doses, and sudden discontinuation can induce withdrawal symptoms, so dosages should be gradually reduced. In case of overdose, severe respiratory depression and seizures may occur, requiring immediate emergency treatment, with naloxone designated as an antidote. This medication should be stored out of reach of children and kept in its original container to prevent misuse or deterioration in quality.

Side effects

  • Convulsions
  • hypersensitivity
  • shock
  • anaphylaxis
  • itching
  • urticaria
  • bronchospasm
  • angioedema
  • respiratory depression
  • dyspnea
Show 80 more
  • exacerbation of asthma
  • hiccups
  • palpitations
  • coldness
  • mimicry worries
  • vasodilation
  • hypotension
  • arrhythmia
  • facial pallor
  • syncope
  • orthostatic hypotension
  • tachycardia
  • bradycardia
  • hypertension
  • drowsiness
  • sleep
  • headache
  • heaviness
  • excitement
  • tremors
  • tinnitus
  • numbness in both hands
  • anxiety
  • exhaustion
  • fatigue
  • lethargy
  • sweating
  • dizziness
  • unsteadiness
  • discomfort
  • difficulty in urination
  • dry mouth
  • thirst
  • confusion
  • cooperation difficulties
  • lucklessness
  • restlessness
  • sleep disorders
  • cognitive disturbances
  • hallucinations
  • forgetfulness
  • concentration difficulties
  • depression
  • changes in appetite
  • sensory disturbances
  • epileptic seizures
  • involuntary muscle contractions
  • weakness
  • sleep apnea syndrome
  • hyperalgesia
  • nausea
  • vomiting
  • abdominal distension
  • abdominal enlargement
  • abdominal pain
  • loss of appetite
  • constipation
  • gastrointestinal irritation
  • hypertonia
  • muscle weakness
  • urinary retention
  • polyuria
  • menopausal syndrome
  • urinary disorders
  • menstrual disorders
  • Stevens-Johnson syndrome
  • skin reactions
  • sweating
  • fatigue
  • withdrawal symptoms
  • panic attacks
  • severe anxiety
  • sensory disturbances
  • tinnitus
  • pupil constriction
  • cardiovascular collapse
  • loss of consciousness
  • coma
  • convulsions
  • dyspnea

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent air exposure, and it is recommended to keep it at a temperature between 1 and 30 degrees Celsius. This helps maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Light gray, biconvex, round, film-coated sustained release tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.